CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
79 hedge funds and large institutions have $166M invested in Cascadian Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 8 closing their positions.
Holders
79
Holders Change
+3
Holders Change %
+3.95%
% of All Funds
1.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
24
Reduced
15
Closed
8
Calls
$164K
Puts
$94K
Net Calls
+$70K
Net Calls Change
+$12K
